Page last updated: 2024-11-03

probucol and Osteonecrosis

probucol has been researched along with Osteonecrosis in 4 studies

Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.

Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.

Research Excerpts

ExcerptRelevanceReference
"Simvastatin and pravastatin significantly reduced the incidence of steroid-induced osteonecrosis in rabbits."7.74Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. ( Asada, A; Iwaki, H; Iwakiri, K; Kaneshiro, Y; Kobayashi, A; Masada, T; Oda, Y; Takaoka, K, 2008)
"We describe that high-dose methylprednisolone (20 mg/kg) can induce multifocal osteonecrosis (ON) in conjunction with thrombocytopenia, hypofibrinogenemia, and hyperlipemia."4.84[Animal models for steroid-induced osteonecrosis]. ( Iwamoto, Y; Miyanishi, K; Motomura, G; Nishida, K; Sueishi, K; Yamamoto, T, 2007)
"Simvastatin and pravastatin significantly reduced the incidence of steroid-induced osteonecrosis in rabbits."3.74Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. ( Asada, A; Iwaki, H; Iwakiri, K; Kaneshiro, Y; Kobayashi, A; Masada, T; Oda, Y; Takaoka, K, 2008)
"To investigate the effects of combination treatment with an anticoagulant (warfarin) plus a lipid-lowering agent (probucol) on the prevention of steroid-induced osteonecrosis (ON) in rabbits."3.72Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. ( Iwamoto, Y; Jingushi, S; Miyanishi, K; Motomura, G; Yamamoto, T, 2004)
"Probucol and warfarin were administered beginning 1 to 2 weeks prior to steroid injection."1.35Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. ( Hirota, Y; Iwamoto, Y; Kondo, K; Miyanishi, K; Motomura, G; Yamamoto, T, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwakiri, K1
Oda, Y1
Kaneshiro, Y1
Iwaki, H1
Masada, T1
Kobayashi, A1
Asada, A1
Takaoka, K1
Motomura, G3
Yamamoto, T3
Miyanishi, K3
Kondo, K1
Hirota, Y1
Iwamoto, Y3
Jingushi, S1
Nishida, K1
Sueishi, K1

Reviews

1 review available for probucol and Osteonecrosis

ArticleYear
[Animal models for steroid-induced osteonecrosis].
    Clinical calcium, 2007, Volume: 17, Issue:6

    Topics: Animals; Anticholesteremic Agents; Anticoagulants; Disease Models, Animal; Dose-Response Relationshi

2007

Other Studies

3 other studies available for probucol and Osteonecrosis

ArticleYear
Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2008, Volume: 13, Issue:5

    Topics: Animals; Cytochrome P-450 CYP3A; Female; Glucocorticoids; Hydroxymethylglutaryl-CoA Reductase Inhibi

2008
Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits.
    The Journal of rheumatology, 2008, Volume: 35, Issue:12

    Topics: Adrenal Cortex Hormones; Animals; Anticholesteremic Agents; Anticoagulants; Biomarkers; Chemoprevent

2008
Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:10

    Topics: Adipocytes; Animals; Anticholesteremic Agents; Anticoagulants; Bone Marrow; Drug Therapy, Combinatio

2004